chr19-36950669-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198539.4(ZNF568):c.1516G>A(p.Val506Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198539.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF568 | NM_198539.4 | c.1516G>A | p.Val506Ile | missense_variant | 7/7 | ENST00000333987.12 | NP_940941.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF568 | ENST00000333987.12 | c.1516G>A | p.Val506Ile | missense_variant | 7/7 | 1 | NM_198539.4 | ENSP00000334685 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249552Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135344
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461644Hom.: 0 Cov.: 38 AF XY: 0.0000165 AC XY: 12AN XY: 727132
GnomAD4 genome AF: 0.000197 AC: 30AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2023 | The c.1516G>A (p.V506I) alteration is located in exon 7 (coding exon 5) of the ZNF568 gene. This alteration results from a G to A substitution at nucleotide position 1516, causing the valine (V) at amino acid position 506 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at